Marsh & McLennan's Q3 Beat Driven by Higher Revenue, UBS Securities Says

12:25 PM EDT, 10/16/2026 (MT Newswires) -- Marsh & McLennan's (MRSH) Q3 results beat was revenue-driven, with organic growth surpassing expectations largely due to the Consulting segment, UBS Securities said in a Thursday note. The company reported Q3 adjusted earnings of $2.03 per share, ahead of UBS' estimate of $1.98 and consensus of $1.97. Consulting organic growth came in at 8%, beating the brokerage's 5% estimate. Analysts said Marsh Risk's sequential organic growth improvement is an encouraging start to broker earnings, while Marsh Re's performance was weaker than expected, with organic revenue declining 6%. Global gross domestic product growth outside of expectations could affect the company's organic revenue growth, particularly within its Consulting operations, according to the note. UBS maintained a buy rating and a $222 price target on the stock. Price: 187.12, Change: +0.58, Percent Change: +0.31